Many studies have attempted to correlate p53 expression status with prognosis or therapeutic response in CRC but have yielded inconsistent results regarding those relationships.12–19 However, the cutoff values that define p53 overexpression according to immunohistochemistry are variable among these studies. Here, TP53 is linked to colorectal carcinoma.